Related Experiment Video
Updated: Jan 28, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Combined Antioxidant and Glucocorticoid Therapy for Safer Treatment of Preterm Birth
Tessa A C Garrud1, Dino A Giussani1
1Department of Physiology Development & Neuroscience, University of Cambridge, Cambridge, UK; Cambridge Cardiovascular Strategic Research Initiative, University of Cambridge, Cambridge, UK; Cambridge Strategic Research Initiative on Reproduction, University of Cambridge, Cambridge, UK.
Insights
Glucocorticoid therapy for preterm infants is effective but may cause harm. Combining it with antioxidants could offer a safer treatment option, reducing risks to infant growth and development.
Area of Science:
- Neonatal medicine
- Pharmacology
- Developmental biology
Background:
- Ante- and postnatal glucocorticoid therapy is a successful clinical translation of basic science, significantly reducing preterm infant morbidity and mortality.
- However, concerns exist regarding potential long-term adverse effects on offspring growth, neurological, and cardiovascular function.
- Evidence stems from human clinical and animal model studies.
Purpose of the Study:
- To explore the potential benefits and safety of combined antioxidant and glucocorticoid therapy compared to glucocorticoid therapy alone for preterm infants.
- To review existing evidence on the long-term effects of glucocorticoid treatment in preterm neonates.
Main Methods:
- Literature review of human clinical studies.
- Literature review of experimental studies in animal models.
- Analysis of evidence regarding combined antioxidant and glucocorticoid therapy.
Main Results:
- Glucocorticoid therapy demonstrates efficacy in reducing immediate preterm infant complications.
- Significant concerns are raised about potential long-term adverse outcomes associated with glucocorticoid use.
- The review investigates the safety profile of adding antioxidants to glucocorticoid regimens.
Conclusions:
- Combined antioxidant and glucocorticoid therapy may represent a safer alternative to glucocorticoid monotherapy for preterm infants.
- Further research is warranted to confirm the safety and efficacy of this combined approach.
- Mitigating long-term adverse effects is a critical consideration in neonatal care for preterm infants.
Abstract:
Ante- and postnatal glucocorticoid therapy reduces morbidity and mortality in the preterm infant, and it is therefore one of the best examples of the successful translation of basic experimental science into human clinical practice. However, accruing evidence derived from human clinical studies and from experimental studies in animal models raise serious concerns about potential long-term adverse effects of treatment on growth and neurological and cardiovascular function in the offspring. This review explores whether combined antioxidant and glucocorticoid therapy may be safer than glucocorticoid therapy alone for the treatment of preterm birth.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Birth Control Methods
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Gene Therapy

